Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.
复制标题
DOI:
10.1177/0748730417696788
复制
发表时间:
2017-04
影响因子:
3.5
通讯作者:
Rubin JB
中科院分区:
文献类型:
--
作者:
Slat EA;Sponagel J;Marpegan L;Simon T;Kfoury N;Kim A;Binz A;Herzog ED;Rubin JB
The safety and efficacy of chemotherapeutics can vary as a function of the time of their delivery during the day. This study aimed to improve the treatment of glioblastoma (GBM), the most common brain cancer, by testing whether the efficacy of the DNA alkylator temozolomide (TMZ) varies with the time of its administration. We found cell-intrinsic, daily rhythms in both human and mouse GBM cells. Circadian time of treatment impacted TMZ sensitivity of murine GBM tumor cells in vitro. The maximum TMZ-induced DNA damage response, activation of apoptosis and growth inhibition occurred near the daily peak in expression of the core clock gene Bmal1. Deletion of Bmal1 (Arntl) abolished circadian rhythms in gene expression and TMZ-induced activation of apoptosis and growth inhibition. These data indicate that tumor cell-intrinsic circadian rhythms are common to GBM tumors and can regulate TMZ cytotoxicity. Optimization of GBM treatment by timing TMZ administration to daily rhythms should be evaluated in prospective clinical trials.
登录
查看更多内容
影响因子:
3.5
作者:
Marpegan L;Krall TJ;Herzog ED
通讯作者:
Herzog ED
影响因子:
4.5
作者:
Liu AC;Tran HG;Zhang EE;Priest AA;Welsh DK;Kay SA
通讯作者:
Kay SA
影响因子:
16
作者:
Gery, S;Komatsu, N;Koeffler, HP
通讯作者:
Koeffler, HP
影响因子:
30.8
作者:
Reilly, KM;Loisel, DA;Jacks, T
通讯作者:
Jacks, T
影响因子:
5.4
作者:
Stevens, RG
通讯作者:
Stevens, RG